About Concept Life Sciences
Concept Life Sciences is a Healthcare company based in Manchester (United Kingdom) founded in 2014 by Michael John Fort, and was acquired by Limerston Capital Partners in April 2023. International laboratory testing and consultancy in life sciences are offered. It operates on a Professional Services model. Concept Life Sciences has completed 4 acquisitions, including Aquila BioMedical, Charnwood Discovery and Concept Life Sciences. Its chief executive, as recorded, is Karl Moss. Concept Life Sciences offers products and services including Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services. Its focus areas include Biotechnology and Drug Discovery. Its competitors include Domainex and CatSci; 2 of its 2 listed competitors have raised funding.
Company details
Concept Life Sciences is involved in providing integrated drug discovery and development services from concept to clinic. Services are offered across various modalities including small molecules, biologics, and cell gene therapies. The company is focused on therapeutic areas such as immuno-oncology, liver disease, oncology, neuroscience, and immunology. Solutions are provided for target validation, hit identification, lead optimization, and candidate selection. Comprehensive biology, chemistry, and ADMET DMPK services are delivered to accelerate drug development timelines for clients in the healthcare sector.
- Headquarters Manchester, United Kingdom
- Founders Michael John Fort
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website conceptlifesciences.com
- Social LinkedIn X
- Acquired by Limerston Capital Partners (Apr 2023)
- Legal Name Concept Life Sciences
- InvestorsSpectris
& 2 more
- Investments & AcquisitionsAquila BioMedical
& 3 more
- Acquired by
Products & Services of Concept Life Sciences
Concept Life Sciences offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services.
Drug discovery services are provided from concept to clinic.
Drug candidate properties are analyzed in vitro and vivo.
Biological targets are validated and mechanisms are studied.
Synthetic and medicinal chemistry solutions are expertly provided.
Funding Insights of Concept Life Sciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Concept Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in Concept Life Sciences
Concept Life Sciences has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Spectris, Equistone Partners Europe and Limerston Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A mid-market private equity firm based in Europe is operated. | equistonepe.com | London, United Kingdom | ||
| limerstoncap.com | ||||
Process monitoring and optimisation services are provided for multiple industries. | 1915 | spectris.com | Egham, United Kingdom |
Investor details for Concept Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Concept Life Sciences
11 people are tracked at Concept Life Sciences (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Michael John Fort | Co-Founder & Chairman | Leadership |
Karl Moss | CEO | Leadership |
David Fengas | Director Of CMC Services | Leadership |
Jonathan Critchley | Chief Financial Officer | Leadership |
Jose Vidal | Section Head | Leadership |
Kenna Harris | Head Of US Sales | Leadership |
Richard Fox | Group Leader | Team |
Jonathan Fray | Lead Chemist | Team |
Rebecca Halstead | Chemist | Team |
Alison Fardon | Core Analytical Laboratory Manager | Team |
Dorothee Lahaye | Quality Officer | Team |
Complete people profiles for Concept Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concept Life Sciences
Concept Life Sciences has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Aquila BioMedical, Charnwood Discovery and Concept Life Sciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Outsourced drug discovery services support pharmaceutical and biotech clients. | charnwooddiscovery.com | 1998 | Nov 2024 | •••• | ||
Preclinical services in immunology, regeneration, neuroscience, and histology are provided. | aquila-bm.com | Edinburgh, United Kingdom | 2011 | Oct 2017 | •••• | |
Concept Life Sciences is engaged in drug discovery and development services. | agenda1.co.uk | Bradford, United Kingdom | 2006 | Oct 2015 | $100M | |
Integrated drug discovery and medicinal chemistry services | peakdale.co.uk | High Peak, United Kingdom | 1992 | Jul 2014 | •••• |
Complete acquisition details for Concept Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Concept Life Sciences
8 dated milestones of Concept Life Sciences across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Concept Life Sciences is founded.
- Acquisition Acquires Peakdale.
- Funding First funding round.
- Acquisition Acquires Concept Life Sciences.
- Acquisition Acquires Aquila BioMedical.
- Exit Acquired by Spectris.
- Exit Acquired by Limerston Capital Partners.
- Acquisition Acquires Charnwood Discovery.
Competitors of Concept Life Sciences
Concept Life Sciences has 2 listed competitors in our database, 2 of them funded. They include Domainex and CatSci.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| domainex.co.uk | 2001 | Cambridge, United Kingdom | $4.97M | 93 | Drug discovery CRO company for epigenetic research and inflammatory diseases | |
| catsci.com | 2010 | Cardiff, United Kingdom | $5.89M | 63 | Drug discovery services are provided to pharmaceutical clients worldwide. |
Detailed competitors of Concept Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Concept Life Sciences
The website of Concept Life Sciences (conceptlifesciences.com) receives about 4.4K visits a month.
- Monthly visits4.4K
▼ 26.5% vs previous month
Websites whose visitors overlap most with Concept Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cleveraccounts.com | 100% | 11.8K | #2,437,231 | View details | |
myriadassociates.com | myriadassociates.com | 87% | #3,478,508 | – | |
etctax.co.uk | etctax.co.uk | 84% | #5,045,162 | – | |
| proteogenix.science | 73% | 26.4K | #984,622 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Concept Life Sciences
Complete news archive for Concept Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concept Life Sciences
Concept Life Sciences was founded in 2014.
Concept Life Sciences is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Karl Moss is the CEO of Concept Life Sciences, as recorded in our data.
Concept Life Sciences is involved in providing integrated drug discovery and development services from concept to clinic. Services are offered across various modalities including small molecules, biologics, and cell gene therapies. The company is focused on therapeutic areas such as immuno-oncology, liver disease, oncology, neuroscience, and immunology. Solutions are provided for target validation, hit identification, lead optimization, and candidate selection. Comprehensive biology, chemistry, and ADMET DMPK services are delivered to accelerate drug development timelines for clients in the healthcare sector.
Concept Life Sciences offers Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services.
Concept Life Sciences has made 4 acquisitions, including Aquila BioMedical, Charnwood Discovery, and Concept Life Sciences.
Concept Life Sciences has 3 investors. Key investors include Spectris, Equistone Partners Europe, and Limerston Capital Partners.
Concept Life Sciences operates through Concept Life Sciences.
Yes. Concept Life Sciences was acquired by Limerston Capital Partners in April 2023.